Study population in biostudies in the EU: mixed or not? [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2017-09-15 20:46 (2853 d 17:08 ago) – Posting: # 17812
Views: 4,021

Dear marcel,

❝ My question is: do you know if there has been any regulatory change on that field which could explain such a question?


As far as I have been told this is a slight anomaly related to some rules that have little to do with GCP or regulatory science. If I got it right it is an equal opportunity issue. I was told CRO's in Jordan cannot in a straightforward and legal manner go out and invite only male participants for a study on a drug taken by both genders. Something like that.

“A customer can have a car painted any color he wants as long as it’s black”   [H. Ford.]

No, not Harrison.:-D

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,687 registered users;
66 visitors (0 registered, 66 guests [including 16 identified bots]).
Forum time: 13:54 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5